Express Scripts Launches $25 Billion Offer for Caremark

Pharmacy-benefits manager Express Scripts said it was starting a $25 billion exchange offer for all outstanding shares of rival Caremark Rx , despite drugstore operator CVS' bid for the company.

CVS said on Nov. 1 it planned to acquire Caremark for about $21.2 billion in stock. Express Scripts launched its bid for Caremark on Dec. 18.

Under terms of the exchange offer, Express Scripts will offer $29.25 in cash and 0.426 shares of stock for each share of Caremark. Based on Friday's closing stock prices, the company said its bid represents a 7% premium over the current CVS proposal.

Caremark's board has voted against Express Scripts' offer.

The exchange offer will expire Feb. 13. Caremark said it was taking the action "in light of the Caremark Board's rejection of and refusal to even discuss our superior proposal."

"CVS remains committed to closing its merger with Caremark in the first quarter of 2007," a company representative said.

Caremark had no immediate comment on the exchange offer.

Contact U.S. News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

  • Rescue efforts are underway in Nepal after a massive earthquake struck near the country's capital, leaving behind a trail of death and destruction.

  • Emily restaurant owner Matthew Hyland banked on a local grower for the freshest basil—and immediately saw his profits take seed.

  • Robot

    Robo-advisors have forced traditional advisors to strategize and rethink the services and value they provide clients.

U.S. Video